Analyst Price Targets — RDNT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2026 9:15 am | Andrew Mok | Barclays | $65.00 | $53.35 | TheFly | RadNet price target lowered to $65 from $70 at Barclays |
| March 3, 2026 3:56 pm | Brian Tanquilut | Jefferies | $91.00 | $72.01 | StreetInsider | Jefferies Reiterates Buy Rating on RadNet (RDNT); "We remain bullish on RDNT" |
| January 9, 2026 10:35 am | — | UBS | $92.00 | $78.38 | TheFly | RadNet initiated with an Overweight at KeyBanc |
| January 8, 2026 9:14 pm | — | KeyBanc | $92.00 | $78.38 | TheFly | RadNet initiated with an Overweight at KeyBanc |
| December 17, 2025 10:06 am | David MacDonald | Truist Financial | $90.00 | $71.23 | StreetInsider | Truist Securities Reiterates Buy Rating on RadNet (RDNT) |
| November 14, 2025 9:24 am | John Ransom | Raymond James | $95.00 | $73.46 | StreetInsider | RadNet (RDNT) PT Raised to $95 at Raymond James |
| September 3, 2025 1:12 pm | — | Truist Financial | $81.00 | $70.95 | TheFly | RadNet price target raised to $81 from $74 at Truist |
| July 10, 2025 2:00 pm | David MacDonald | Truist Financial | $74.00 | $57.28 | StreetInsider | Truist on RadNet (RDNT): 'Positive EBCD Reimbursement Update From SC' |
| January 22, 2025 1:40 pm | David MacDonald | Truist Financial | $88.00 | $61.77 | TheFly | RadNet price target lowered to $88 from $94 at Truist |
| December 5, 2024 5:10 pm | Brian Tanquilut | Jefferies | $100.00 | $79.16 | StreetInsider | RadNet (RDNT) PT Raised to $100 at Jefferies |
Latest News for RDNT
RadNet NASDAQ: RDNT said it has signed a definitive agreement to acquire teleradiology and hospital radiology-services provider ONRAD Inc. in a transaction designed to establish a third operating segment focused on radiology professional services.
RadNet, Inc. (RDNT) M&A Call Transcript
RadNet announces agreement to acquire ONRAD, combining radiology professional services, AI solutions and outpatient imaging into an integrated offering.
RadNet (NASDAQ: RDNT - Get Free Report) and Joint (NASDAQ: JYNT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Valuation and Earnings This table compares RadNet and Joint"s revenue,
SOMERVILLE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced new findings published in European Radiology supporting that AI applications within DeepHealth's Prostate MR Solution1 could help clinicians decide more confidently which men may need a prostate biopsy, particularly when…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RDNT.
U.S. House Trading
No House trades found for RDNT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.